Clinical Trials for Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma

Find clinical trials for recurrent head and neck cutaneous squamous cell carcinoma. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

NCT ID: NCT06568172

This clinical trial is studying whether adding an immunotherapy drug called cemiplimab to standard treatment (surgery with or without radiation) can improve outcomes for patients with advanced skin...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, New Haven, Connecticut, United States +107 more

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

NCT ID: NCT06980038

This clinical trial is exploring whether a combination of two treatments, cemiplimab (REGN2810) and CDX-1140, is more effective than using cemiplimab alone for patients with advanced head and neck ...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions